Please let us know by filling out a patient satisfaction survey when you get one. You can also leave an online review by clicking the button below.
- A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer. Massarweh S, Tham YL, Huang J, Sexton K, Weiss H, Tsimelzon A, Beyer A, Rimawi M, Cai WY, Hilsenbeck S, Fuqua S and Elledge R. Breast Cancer Res Treat 129:819-27, 2011.
- Bayesian Monitoring of a phase II chemoprevention trial in high risk cohorts for prostate cancer. Weiss HL, Urban DA, Grizzle WE, Cronin KA, Freedman LS, Kelloff GJ, Lieberman R. Urology 57(4A):220-223, 2001.
Cancer Center Member
Design and analysis of early phase clinical trials focusing on Bayesian design and interim monitoring. Statistical analysis of transgenic, xenograft and chemically induced mouse models of cancer.